共 50 条
- [31] Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (04): : 396 - 405
- [33] EFFECT OF FLIBANSERIN ON BODY WEIGHT DURING TREATMENT FOR HYPOACTIVE SEXUAL DESIRE DISORDER IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E97 - E97
- [34] Safety of Flibanserin in Women With Hypoactive Sexual Desire Disorder Taking Antidepressant Medications OBSTETRICS AND GYNECOLOGY, 2018, 131 : 41S - 41S
- [36] SAFETY OF FLIBANSERIN IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER TAKING ANTIDEPRESSANT MEDICATIONS JOURNAL OF SEXUAL MEDICINE, 2019, 16 (04): : S74 - S74
- [37] SAFETY OF FLIBANSERIN IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER TAKING ANTIDEPRESSANT MEDICATIONS JOURNAL OF UROLOGY, 2018, 199 (04): : E1051 - E1051
- [38] Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women JOURNAL OF SEXUAL MEDICINE, 2007, 4 : 227 - 234
- [39] Testosterone use for hypoactive sexual desire disorder in postmenopausal women MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2023, 30 (07): : 781 - 783
- [40] Clinical management of hypoactive sexual desire disorder in postmenopausal women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (09): : 1083 - 1085